Company Search:
Advanced Search
Sponsored Links
Vertex Pharmaceuticals Inc Company Snapshot
Vertex Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vertex Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Perrigo Company PLC (2020 sales of $5.06 billion of which 53% was CSCA), Zoetis Inc ($6.68 billion of which 53% was US), and Alexion Pharmaceuticals, Inc. ($6.07 billion of which 67% was Soliris).

Sales Analysis. During the second quarter of 2021, sales at Vertex Pharmaceuticals Inc totalled $1.79 billion. This is an increase of 17.6% from the $1.52 billion in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled $3.52 billion, which is 15.7% higher than through the first two quarters of 2020. During the previous 13 quarters, sales at Vertex Pharmaceuticals Inc have increased compared with the same quarter in the previous year. During the year ended December of 2020, sales at Vertex Pharmaceuticals Inc were $6.21 billion. This is an increase of 49.1% versus 2019, when the company's sales were $4.16 billion. This was the fifth consecutive year of sales increases at Vertex Pharmaceuticals Inc (and since 2015, sales have increased a total of 501%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vertex Pharmaceuticals Inc
  Stock Performance Chart for Vertex Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/8/2021): 178.94
(Figures in U.S. Dollars)
1 Week -0.8%   13 Weeks -5.1%  
4 Weeks -9.7%   52 Weeks -33.7%  
Vertex Pharmaceuticals Inc Key Data:
  Ticker: VRTX Country: United States
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 6,205,683,000
(Year Ending Jan 2021).
Employees: 3,400
  Currency: U.S. Dollars Market Cap: 46,365,859,160
  Fiscal Yr Ends: December Shares Outstanding: 259,114,000
  Share Type: Common Closely Held Shares: 337,340
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.